By Sheeba M. | Weedstock Market Intelligence
Monday, September 28, 2026
The cannabis sector enters Monday afternoon trading in accumulation posture, with the DEA rescheduling final-4 countdown dominating institutional positioning across the MSO and LP universe. Monday’s midday scoreboard reflects broad-based sector strength with volume profiles suggesting institutional buyers are establishing or adding to positions ahead of what the market increasingly views as a high-probability October catalyst window.
Monday Afternoon MSO Scoreboard
- Curaleaf Holdings (CURLF) — Midday volume running above 20-day average. Florida and New York operations represent primary market sensitivity to rescheduling. Management restructuring execution in 2025-2026 has reduced the debt overhang that previously suppressed institutional interest.
- Green Thumb Industries (GTBIF) — Illinois-anchored stability story attracting accumulation. Q3 earnings preview bid active through midday. RHYTHM brand data from Illinois monthly reports continues to support brand equity thesis. Cleanest balance sheet in large-cap MSO universe.
- Verano Holdings (VRNOF) — Florida and Illinois dual-market operator seeing increased bid activity. ZEN Leaf retail brand recognition becoming a factor in institutional models evaluating dispensary network value.
- Trulieve Cannabis (TCNNF) — Florida-dominant operator with highest single-state concentration risk in the MSO universe. Adult-use Florida optionality premium being re-evaluated by analysts tracking Tallahassee legislative activity.
- AYR Wellness — Smaller-cap MSO seeing activity consistent with sector rotation into higher-beta names as DEA confidence builds.
Canadian LPs With US Exposure
- Canopy Growth (CGC) — US re-entry positioning through Acreage Holdings warrants and Wana Brands option remain the primary investment thesis. Acreage trigger mechanism tied to federal legalization creates binary upside structure distinct from pure MSO plays.
- Tilray Brands (TLRY) — Dual cannabis/beverages model trading on DEA sentiment with secondary bid from beverage segment performance. US cannabis re-entry thesis provides optionality being priced in more aggressively.
- OrganiGram Holdings (OGI) — International cannabis portfolio including European medical market exposure providing differentiated narrative. BAT strategic partnership continues to fund innovation pipeline.
DEA Final-4 Countdown: What October Looks Like
- Final ruling publication: Federal Register publication expected within the October catalyst window based on administrative process tracking
- Effective date: Schedule III reclassification typically takes effect 30 days post-publication, creating November/December 280E elimination affecting full-year 2026 tax filings
- 280E cliff: Elimination is not retroactive — 2025 taxes filed under 280E — but forward 2026 Q4 and all of 2027 reflect normalized corporate tax rates
- Banking access: Schedule III does not immediately resolve SAFE Banking, but creates political pathway momentum analysts are treating as a 2027 probability
Earnings Calendar: Q3 2026 Setup
With Q3 2026 results expected to begin reporting in late October and November, the sector enters its pre-earnings quiet period. Most MSOs saw stabilized or slight sequential growth in Q2 2026; Q3 expectations are for continued stabilization with margin improvement thesis intact. Analysts are publishing dual 280E/Schedule III models creating wider-than-usual EPS estimate ranges that benefit names with cleaner operating income profiles.
Institutional Flow Read: Monday Afternoon
- New position initiation: Evident in GTBIF and VRNOF where volume distribution shows accumulation characteristics (buying concentrated in price stability periods rather than momentum chasing)
- Position sizing up: Larger existing holders adding to CURLF on any intraday weakness, consistent with conviction-building ahead of a known catalyst
- LP to MSO rotation: Some selling pressure in Canadian names absorbed by buying in US-operators, consistent with Schedule III benefiting US operators more directly near-term
Tuesday Pre-Market Setup
Heading into Tuesday September 29, 2026: DEA final-3 countdown pressure intensifies — each passing day without a ruling increases the probability that the final ruling drops any given day. Overnight news flow from Canadian LP operations, any Monday close institutional rebalancing creating Tuesday morning opening range opportunities, and pre-earnings analyst note activity as Q3 reporting season approaches will all shape the session.
The cannabis sector’s Monday afternoon posture is the most constructively positioned it has been in the current cycle. With the DEA catalyst countdown in final stages, earnings season approaching, and institutional positioning showing accumulation characteristics, the risk/reward for informed sector participants remains asymmetrically positioned to the upside contingent on regulatory execution that the market is now pricing as high probability.
This article is for informational purposes only and does not constitute investment advice. Cannabis equities involve significant risk including regulatory uncertainty, liquidity constraints, and sector-specific volatility.